1. Insider Unloading: Oleg Movchan Sells $1.51M Worth Of Enfusion Shares

    By Benzinga Insights Disclosed on December 6, Oleg Movchan , Chief Executive Officer at Enfusion (NYSE: ENFN ), executed a substantial insider sell as per the latest SEC filing. What Happened: A Form 4 filing with the U.S. Securities and Exchange Commission on Wednesday outlined that